Guidant on the night of Friday, January 13, 2006 accepted a "definitive" offer of $71 a share, or $24.2bn, from Johnson & Johnson in the latest twist in the two-way bid battle with Boston Scientific for the US heart devicemaker.
J&J's offer was raised for a second time this week, but is still at a 3 per cent discount to the $25.5bn tabled by Boston on Thursday.
I'm a patent lawyer located in central New Jersey. I have a J.D. from the University of Chicago and a Ph.D. from Stanford University, where I studied graphite intercalation compounds at the Center for Materials Research. I worked at Exxon Corporate Research in areas ranging from engine deposits through coal and petroleum to fullerenes. An article that I wrote in The Trademark Reporter, 1994, 84, 379-407 on color trademarks was cited by Supreme Court in Qualitex v. Jacobson, 514 US 159 (1995) and the methodology was adopted
in the Capri case in N.D. Ill. An article that I wrote on DNA profiling was cited by the Colorado Supreme Court (Shreck case) and a Florida appellate court (Brim case). I was interviewed by NHK-TV about the Jan-Hendrik Schon affair. I am developing ipABC, an entity that combines rigorous IP analytics with study of business models, to optimize utilization of intellectual property. I can be reached at C8AsF5 at yahoo.com.
0 Comments:
Post a Comment
<< Home